1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
RareCare Patient Assistance Programs is a suite of programs from the National Organization for Rare Disorders (NORD) that funds financial assistance for individuals living with rare diseases.
Since 1987, NORD has offered programs covering life-saving medications, insurance premium and co-pay assistance, diagnostic testing, travel assistance for clinical trials or specialist consultations, caregiver respite, emergency relief, and educational support. Programs vary by rare disease and may be open for applications, waitlisting, or closed depending on current funding.
Eligible applicants are individuals diagnosed with qualifying rare diseases who cannot otherwise afford critical treatments or care.
Get alerted about grants like this
Get emailed when new opportunities from “National Organization for Rare Disorders (NORD)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Patient Assistance Programs - National Organization for Rare Disorders Patient & Caregiver Assistance Rare Disease Centers of Excellence Sobre los Centros de Excelencia Apply (Medical Institutions only) Information on Clinical Trials & Research Studies Find Clinical Trials & Research Studies Finding a Support Organization RareEdu ® – Online Learning Platform NORD provides more including our Rare Disease Educational Support Program and Rare Caregiver Respite Program .
Patient Assistance Programs NORD’s Patient Assistance Programs Since 1987, NORD has provided assistance programs to help patients obtain life-saving or life-sustaining medication they could not otherwise afford. These programs provide medication, financial assistance with insurance premiums and co-pays, diagnostic testing assistance, and travel assistance for clinical trials or consultation with disease specialists.
Filter by Program Status > Select an option Accepting Applications Accepting new applications and re-enrollments for current year Accepting new applications and re-enrollments for next year Closed Not yet accepting applications for current year Referral Required Temporarily Waitlisting Filter by Program Types > Select an option Clinical Trial Support Emergency Relief Program Medical Assistance Premium and Copay Accepting Applications --> Acid Sphingomyelinase Deficiency (ASMD) Medical Assistance ASMD PremiumCopay&MedicalAssistanceAug2024 Accepting Applications --> Acid Sphingomyelinase Deficiency (ASMD) Premium Copay ASMD PremiumCopay&MedicalAssistanceAug2024 Accepting new applications and re-enrollments for current year --> Alpha-1 Antitrypsin Deficiency Premium Copay Assistance Accepting new applications and re-enrollments for current year Alpha-1 PremiumCopayAssistance-July2024 Temporarily Waitlisting --> Amyloidosis Medical Assistance Temporarily Waitlisting --> Amyloidosis Premium Copay Assistance Accepting Applications --> Amyotrophic Lateral Sclerosis (ALS) Travel & Lodging Assistance AT-01 Phase 3 Imaging Study AT01-301 Phase 3 Imaging Agent Study_flyer 12_04_24 Accepting Applications --> atypical Hemolytic Uremic Syndrome (aHUS) Emergency Relief Accepting new applications and re-enrollments for current year --> atypical Hemolytic Uremic Syndrome (aHUS) Medical Assistance Accepting new applications and re-enrollments for current year aHUS_PremiumCopay&MedicalAssistance-July2024 Accepting new applications and re-enrollments for current year --> atypical Hemolytic Uremic Syndrome (aHUS) Premium Copay Assistance Accepting new applications and re-enrollments for current year aHUS_PremiumCopay&MedicalAssistance-July2024 Accepting Applications --> Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Medical Assistance aPAP T&L Assistance2026 (1) Azitra NTH-1201 Study Travel Assistance NTH-1201 (NethertonSyndrome) -Azitra-June2024 Accepting new applications and re-enrollments for current year --> Bardet-Biedl Syndrome (BBS) Premium Copay Assistance Accepting new applications and re-enrollments for current year PAP_PremCopay_BBS flyer , PAP_PremCopay_BBS-flyer SPANISH Accepting Applications --> Barth Syndrome Emergency Relief BarthSyndrome ERF Revised -3-2023 Accepting Applications --> Barth Syndrome Travel Assistance Fund 2026 Barth Syndrome Foundation Family Services Fund (3) Batten Disease Emergency Relief Accepting Applications --> Batten Disease Medical Assistance Batten-PremiumCopayMedicalAssist-2026 (2) Accepting new applications and re-enrollments for current year --> Batten Disease Premium Copay Assistance Accepting new applications and re-enrollments for current year Batten-PremiumCopayMedicalAssist-2026 (2) Accepting new applications and re-enrollments for current year --> Bile Acid Synthesis and Zellweger Spectrum Disorders Medical Assist Accepting new applications and re-enrollments for current year BASD_ZSD-PremiumCopay&MedicalAssistance Accepting new applications and re-enrollments for current year --> Bile Acid Synthesis and Zellweger Spectrum Disorders Premium Copay Assistance Accepting new applications and re-enrollments for current year BASD_ZSD-PremiumCopay&MedicalAssistance Accepting new applications and re-enrollments for current year --> Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Copay Assistance Accepting new applications and re-enrollments for current year Accepting Applications --> Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Emergency Relief Accepting Applications --> Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Travel & Lodging Assistance Accepting Applications --> Cerebrotendinous Xanthomatosis (CTX) Medical Assistance CTX-PremCopay&Medical Assist-2026 Accepting new applications and re-enrollments for current year --> Cerebrotendinous Xanthomatosis (CTX) Premium Copay Assistance Accepting new applications and re-enrollments for current year CTX-PremCopay&Medical Assist-2026 Chronic Granulomatous Disease (CGD) Copay Assistance CGD-PAP , CGD-PAP-Spanish Chronic Granulomatous Disease (CGD) Medical Assistance CGD-PAP , CGD-PAP-Spanish Accepting new applications and re-enrollments for current year --> Chronic inflammatory demyelinating polyneuropathy (CIDP) Medical Assistance Accepting new applications and re-enrollments for current year CIDP-PremiumCopay&MedicalAssistance-Jan.
2025 (4) Accepting new applications and re-enrollments for current year --> Chronic inflammatory demyelinating polyneuropathy (CIDP) Premium Copay Assistance Accepting new applications and re-enrollments for current year CIDP-PremiumCopay&MedicalAssistance-Jan.
2025 (4) Accepting new applications and re-enrollments for current year --> Classical Homocystinuria (HCU) Medical Assistance Accepting new applications and re-enrollments for current year MedicalAssist_Classical HCU-2026 (6) CureDuchenne Educational T&L Support CureDuchenne Educational Support T&L , CureDuchenne Educational Support T&L- Spanish Accepting new applications and re-enrollments for current year --> Cushings Syndrome Medical Assistance Accepting new applications and re-enrollments for current year Cushing's-PremCopay&Medical Assist-Aug2024 Accepting new applications and re-enrollments for current year --> Cushings Syndrome Premium Copay Assistance Accepting new applications and re-enrollments for current year Cushing's-PremCopay&Medical Assist-Aug2024 Accepting new applications and re-enrollments for current year --> Cystinosis Copay Assistance Accepting new applications and re-enrollments for current year Cystinosis-Copay&MedicalAssistance-Aug2024 Accepting new applications and re-enrollments for current year --> Cystinosis Medical Assistance Accepting new applications and re-enrollments for current year Cystinosis-Copay&MedicalAssistance-Aug2024 Accepting new applications and re-enrollments for current year --> Cystinuria Medical Assistance Accepting new applications and re-enrollments for current year Cystinuria-PremCopay&Medical Assist-Aug2024 Accepting new applications and re-enrollments for current year --> Cystinuria Premium Copay Assistance Accepting new applications and re-enrollments for current year Cystinuria-PremCopay&Medical Assist-Aug2024 DISC-1459 Erythropoietic Protoporphyria (EPP) Study Travel & Lodging Assistance Accepting new applications and re-enrollments for current year --> Duchenne Muscular Dystrophy Medical Assistance Accepting new applications and re-enrollments for current year DMD-PremiumCopay&MedicalAssistanceAugust2024 , DMD-PremiumCopay&MedicalAssistance-Spanish (1) Accepting new applications and re-enrollments for current year --> Duchenne Muscular Dystrophy Premium Copay Assistance Accepting new applications and re-enrollments for current year DMD-PremiumCopay&MedicalAssistanceAugust2024 , DMD-PremiumCopay&MedicalAssistance-Spanish (1) Accepting Applications --> Eva’s Butterfly Wishes Experience for Rare Children (5 and under) Eva's Butterfly Wishes-2025 Accepting Applications --> Fabry Disease Medical Assistance Fabry_PremiumCopay&MedicalAssistanceJuly2024 Accepting Applications --> Fabry Disease Premium Copay Assistance Fabry_PremiumCopay&MedicalAssistanceJuly2024 Not yet accepting applications for current year --> Floxuridine Medication Assistance Not yet accepting applications for current year Floxuridine-Medication Assistance 2025 (1) Accepting new applications and re-enrollments for current year --> Gaucher Disease Medical Assistance Accepting new applications and re-enrollments for current year Gaucher-PremCopay&Medical Assist-March2025 Accepting new applications and re-enrollments for current year --> Gaucher Disease Premium Copay Assistance Accepting new applications and re-enrollments for current year Gaucher-PremCopay&Medical Assist-March2025 Accepting Applications --> Guillain-Barre Emergency Relief Assistance PAP_EmergRelief_GBS-July2024 Accepting new applications and re-enrollments for current year --> Hunter Syndrome Medical Assistance Accepting new applications and re-enrollments for current year HunterSyndrome-PremiumCopay&MedicalAssistanceAug2024 (1) Accepting new applications and re-enrollments for current year --> Hunter Syndrome Premium Copay Assistance Accepting new applications and re-enrollments for current year HunterSyndrome-PremiumCopay&MedicalAssistanceAug2024 (1) Accepting Applications --> Hypophosphatasia (HPP) Emergency Relief For Patients & Caregivers For Clinicians & Researchers Make 2026 Count: Gift research, care, and advocacy for families everywhere Your gift today fuels progress in the lab, in clinics, on Capitol Hill and for rare families who can’t wait another year for answers.
Access State Report Card Data Please complete this form to access the requested resource. Please consider sharing some basic information with us.
I am a/an (choose all the apply) (Required) Patient Caregiver / Family Member / Friend Patient Organization Leader/Staff/Volunteer Student / Trainee Healthcare Professional Academic / Research / Education Professional Bio/Pharma Representative Technology Company Representative Attorney / Legal Professional Government / Policy / Legislative Media / Journalist Philanthropist / Investor Other Consent (Required) I agree to receive email communications from NORD.
This field is hidden when viewing the form This field is for validation purposes and should be left unchanged. I show my stripes for... (Required) Max.
5 words Photo (Required) Max file size 5MB. Min. image size 260px X 260px Your Message (Required) Max.
15 words Consent (Required) I agree to the terms and conditions In these Standard Terms and Conditions, “Your Content” refers to any audio, video, text, images, or other material you provide or display. By providing “Your Content”, you grant NORD a license to read, use, reproduce, adapt, modify, publish, translate, and distribute the content in our marketing materials and to all media.
“Your Content” must be your own and must not invade any third‐party’s rights. When you submit content or information to NORD, you are allowing the public to access and use that information, and to associate it with you. NORD reserves the right to remove “Your Content” at any time, without notice.
We take your privacy very seriously. Subject to the Terms and Conditions above, NORD will never sell or disclose your personal information. Comments This field is for validation purposes and should be left unchanged.
Comments (Required) Please let us know what's on your mind. Have a question for us? Ask away.
Instagram This field is for validation purposes and should be left unchanged. Accepted file types: jpeg, png, jpg, Max. file size: 3 MB.
Comments (Required) Please let us know what's on your mind. Have a question for us? Ask away.
According to the current listing, eligibility includes: Individuals living with rare diseases. Confirm the full requirements in the official notice before applying.
RareCare® Patient Assistance Programs is funded by National Organization for Rare Disorders (NORD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NORD Rare Disease Research Grants Program is sponsored by National Organization for Rare Disorders (NORD). NORD Research Grants provide seed grants to academic scientists for translational or clinical studies that further the development of potential new diagnostics or treatments of rare diseases. The grants are competitive and international. NORD accepts gifts restricted to research grant funds in support of a specific rare disease or to NORD's general research grant fund. Awards are based solely on scientific merit. This program has previously funded research for Homocystinuria and related disorders.
NORD Rare Disease Research Grant Program is sponsored by National Organization for Rare Disorders (NORD). NORD's Research Grants provide seed funding to academic scientists for translational or clinical studies that advance the development of potential new diagnostics or treatments for rare diseases. The program prioritizes diseases with few other funding sources. While primarily for academic scientists, small businesses collaborating with eligible institutions may find this relevant.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
On June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read articleOn May 19, the Department of Energy's Office of Critical Minerals and Energy Innovation announced 19 selections under FOA 3105 — two pilot-scale facilities for magnesium and rare-earth separation, and 17 technology development projects spanning lithium, cobalt, nickel, graphite, silicon, and manganese. Here is what the selection list tells researchers and small businesses about where DOE wants the supply chain in 18 months — and where the next solicitations will go.
Read articleDOE's Critical Minerals and Materials Accelerator funds lithium extraction, rare earth recycling, and semiconductor-grade refining. Staggered deadlines run through July 2026.
Read article